[Effect of erythromycin on the fecal flora of infants less than 1-year old]. 1986

M J Butel, and Y Boussougant

Erythromycin ethyl succinate is an antibiotic frequently administered in pediatrics. According to some authors, this drug sharply decreases the fecal count of enterobacteria. The fecal flora of 12 infants less than one year old, treated by erythromycin ethyl succinate for 7 to 10 days was studied by differential count. A variable effect was observed on enterobacteria: a 10(3) to 10(5) fold reduction in 9 cases with a final count superior or equal to 10(4) per gram of feces, with or without coming back to the initial count; in 3 cases no modification. MIC of enterobacteria and concentrations of erythromycin in feces were not predictives of flora variation. Anaerobic flora was weakly modified. No implantation of potentially-pathogenic bacteria or multi-resistant or highly erythromycin resistant enterobacteria occurred. Thus, erythromycin ethyl succinate is valuable in pediatrics as it does not disturb barrier effects. But its use for selective decontamination of gut must be discussed depending on pharmacologic form and posology administered.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D004755 Enterobacteriaceae A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock. Coliform Bacilli,Enterobacteria,Ewingella,Leclercia,Paracolobactrum,Sodalis
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015643 Erythromycin Ethylsuccinate A macrolide antibiotic, produced by Streptomyces erythreus. This compound is an ester of erythromycin base and succinic acid. It acts primarily as a bacteriostatic agent. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Monomycin,E-Mycin E,EryPed,Erythroped,Eyrthromycin Ethyl Succinate,Pediamycin,Wyamycin E,EMycin E,Ethyl Succinate, Eyrthromycin,Ethylsuccinate, Erythromycin,Succinate, Eyrthromycin Ethyl

Related Publications

M J Butel, and Y Boussougant
December 1977, Fel'dsher i akusherka,
M J Butel, and Y Boussougant
January 1964, Annales de radiologie,
M J Butel, and Y Boussougant
May 1957, Journal de medecine de Lyon,
M J Butel, and Y Boussougant
January 1954, Pediatrie,
M J Butel, and Y Boussougant
January 1958, Archiv fur Kinderheilkunde,
M J Butel, and Y Boussougant
January 1995, Revista cubana de medicina tropical,
M J Butel, and Y Boussougant
April 1987, Pediatric nephrology (Berlin, Germany),
Copied contents to your clipboard!